GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Australia ,United States ,New Zealand ,Philadelphia ,Pennsylvania ,Middlesex ,United Kingdom General ,United Kingdom ,Washington ,Brentford ,Hounslow ,Canada ,London ,City Of ,Judy Stewart ,Simon Moore ,Kathleen Quinn ,Josh Williams ,Jeff Mclaughlin ,Sonya Ghobrial ,Sean Clements ,Mick Readey ,Tim Foley ,James Dodwell ,Nick Stone ,Centers For Disease ,Us Centers For Disease ,World Health Organization ,Drug Administration ,School Year ,Advisory Committee On Immunization Practices ,Public Health ,Company Annual Report On Form ,International Journal Of Environmental Research ,Us Medical Affairs ,Rubella Vaccine ,Senior Vice President ,Disease Control ,For Children ,Temi Folaranmi ,Vice President ,Vaccines Therapeutic Area Head ,Immunization Practices ,Annual Report ,West Road ,About Global Measles ,Congenital Rubella Syndrome ,Accessed May ,Current Status ,Mumps Virus Infection ,International Journal ,Environmental Research ,Immunization Analysis ,Selected Vaccines ,Exemption Rates Among Children ,Mortal Wkly Rep ,What Everyone Should ,Business Wire ,Covid 19 ,Health ,Measles ,Rubella ,Mumps ,